Skip to main content

Corporate insider profile

Jamie L. Reynoso Insider Trades

Latest reported as CEO, Medicare Advantage of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).

Purchase filings
0
Reported companies
1
Net open-market value
-$419,088.56
Latest transaction
Oct 19, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 19, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale4,066$4.41$17,931
Oct 15, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale18,273$4.68$85,518
Oct 7, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale2,006$4.63$9,288
Oct 5, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale8,750$4.42$38,675
Sep 17, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale1,921$4.56$8,760
Sep 15, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale9,273$4.78$44,325
Jul 17, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale4,839$4.53$21,921
Jul 15, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale13,119$4.67$61,266
Jul 8, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale2,384$4.68$11,157
Jul 6, 2026CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)CEO, Medicare AdvantageSale6,229$5.26$32,765